Mesoporous bioactive glass scaffolds for efficient delivery of vascular endothelial growth factor

In this article, we, for the first time, investigated mesoporous bioactive glass scaffolds for the delivery of vascular endothelial growth factor. We have found that mesoporous bioactive glass scaffolds have significantly higher loading efficiency and more sustained release of vascular endothelial growth factor than non-mesoporous bioactive glass scaffolds. In addition, vascular endothelial growth factor delivery from mesoporous bioactive glass scaffolds has improved the viability of endothelial cells. The study has suggested that mesopore structures in mesoporous bioactive glass scaffolds play an important role in improving the loading efficiency, decreasing the burst release, and maintaining the bioactivity of vascular endothelial growth factor, indicating that mesoporous bioactive glass scaffolds are an excellent carrier of vascular endothelial growth factor for potential bone tissue engineering applications.

[1]  Wei Fan,et al.  Hypoxia-mimicking mesoporous bioactive glass scaffolds with controllable cobalt ion release for bone tissue engineering. , 2012, Biomaterials.

[2]  Stefan Kaskel,et al.  Proliferation, differentiation and gene expression of osteoblasts in boron-containing associated with dexamethasone deliver from mesoporous bioactive glass scaffolds. , 2011, Biomaterials.

[3]  G. Cuniberti,et al.  Multifunctional magnetic mesoporous bioactive glass scaffolds with a hierarchical pore structure. , 2011, Acta biomaterialia.

[4]  Hojjat Naderi,et al.  Review paper: Critical Issues in Tissue Engineering: Biomaterials, Cell Sources, Angiogenesis, and Drug Delivery Systems , 2011, Journal of biomaterials applications.

[5]  Yinghong Zhou,et al.  A comparative study of mesoporous glass/silk and non-mesoporous glass/silk scaffolds: physiochemistry and in vivo osteogenesis. , 2011, Acta biomaterialia.

[6]  Okşan Karal-Yilmaz,et al.  Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique , 2011, Journal of microencapsulation.

[7]  W. Murphy,et al.  A Modular, Hydroxyapatite‐Binding Version of Vascular Endothelial Growth Factor , 2010, Advanced materials.

[8]  Huaiyong Zhu,et al.  Bioactive mesopore-glass microspheres with controllable protein-delivery properties by biomimetic surface modification. , 2010, Journal of biomedical materials research. Part A.

[9]  Carlos Ortiz-de-Solorzano,et al.  Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Yin Xiao,et al.  Structure-property relationships of silk-modified mesoporous bioglass scaffolds. , 2010, Biomaterials.

[11]  Aldo R Boccaccini,et al.  Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences. , 2010, Tissue engineering. Part B, Reviews.

[12]  Enrica Briganti,et al.  A composite fibrin-based scaffold for controlled delivery of bioactive pro-angiogenetic growth factors. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Jiang Chang,et al.  Surface Modification of Bioactive Glasses and Preparation of PDLLA/Bioactive Glass Composite Films , 2009, Journal of biomaterials applications.

[14]  Richard Appleyard,et al.  The effect of mesoporous bioactive glass on the physiochemical, biological and drug-release properties of poly(DL-lactide-co-glycolide) films. , 2009, Biomaterials.

[15]  W. Saltzman,et al.  Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Stefan Kaskel,et al.  Comparison of the in vitro bioactivity and drug release property of mesoporous bioactive glasses (MBGs) and bioactive glasses (BGs) scaffolds , 2009 .

[17]  M. Gümüşderelioğlu,et al.  In Vitro Release of Dexamethasone or bFGF from Chitosan/Hydroxyapatite Scaffolds , 2009, Journal of biomaterials science. Polymer edition.

[18]  María Vallet-Regí,et al.  Mesoporous Materials for Drug Delivery , 2008 .

[19]  A Lode,et al.  Calcium phosphate bone cements, functionalized with VEGF: release kinetics and biological activity. , 2007, Journal of biomedical materials research. Part A.

[20]  常江.  Well-ordered mesoporous bioactive glasses(MBG):A promising bioactive drug delivery system , 2006 .

[21]  M. Vallet‐Regí.  Ordered Mesoporous Materials in the Context of Drug Delivery Systems and Bone Tissue Engineering , 2006 .

[22]  Jiang Chang,et al.  Porous akermanite scaffolds for bone tissue engineering: preparation, characterization, and in vitro studies. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.

[23]  D. Zhao,et al.  The in-vitro bioactivity of mesoporous bioactive glasses. , 2006, Biomaterials.

[24]  M. Vallet‐Regí,et al.  Hexagonal ordered mesoporous material as a matrix for the controlled release of amoxicillin , 2004 .

[25]  M. Vallet‐Regí,et al.  Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[26]  David J Mooney,et al.  Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[27]  M. Schaffler,et al.  Prevention of fracture healing in rats by an inhibitor of angiogenesis. , 2001, Bone.

[28]  M. Vallet‐Regí,et al.  A New Property of MCM-41: Drug Delivery System , 2001 .

[29]  Anthony Atala,et al.  Systems for therapeutic angiogenesis in tissue engineering , 2000, World Journal of Urology.

[30]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.